Warfarin sodium and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Warfarin sodium (warfarin sodium) and Pataday (olopatadine hydrochloride). Common drug interactions include chronic kidney disease among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Warfarin sodium and Pataday. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Warfarin sodium?

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 71,174 Warfarin sodium users. Check the latest studies of Warfarin sodium.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.



On Jul, 20, 2026

30 people who take Warfarin sodium and Pataday together, and have interactions are studied.

Warfarin sodium and Pataday drug interactions.

What are the common drug interactions of Warfarin Sodium and Pataday, by gender? *:

female:

  1. Chronic kidney disease
  2. Calcium metabolism disorder (occur when the body has too little or too much calcium)
  3. Cardiac failure congestive
  4. Cough
  5. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  6. Diarrhoea
  7. Eye irritation
  8. Fatigue (feeling of tiredness)
  9. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  10. Hepatic enzyme increased

male:

  1. Asthma
  2. Back pain
  3. Blood pressure increased
  4. Chronic kidney disease
  5. Cough
  6. Depression
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Nerve injury
  10. Pneumonia

What are the common drug interactions of Warfarin Sodium and Pataday, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Chronic kidney disease
  5. Emotional distress
  6. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Pain

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Fatigue (feeling of tiredness)
  5. Seizure (abnormal excessive or synchronous neuronal activity in the brain)

60+:

  1. Cough
  2. Dyspnoea (difficult or laboured respiration)
  3. Blood pressure increased
  4. Chills (felling of cold)
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  7. Diarrhoea
  8. Drug hypersensitivity
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 23.33%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 13.33%
  3. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 10.00%
  4. Pain: 3 people, 10.00%
  5. Multiple Myeloma (cancer of the plasma cells): 3 people, 10.00%
  6. Drowsiness: 3 people, 10.00%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 10.00%
  8. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 6.67%
  9. Neuralgia (pain in one or more nerves): 2 people, 6.67%
  10. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Warfarin sodium and Pataday?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Warfarin sodium and Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Warfarin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pataday:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Warfarin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pataday and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on warfarin sodium and olopatadine hydrochloride (the active ingredients of Warfarin sodium and Pataday, respectively), and Warfarin sodium and Pataday (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: